Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Lerapolturev by Istari Oncology for High-Grade Glioma: Likelihood of Approval
Lerapolturev is under clinical development by Istari Oncology and currently in Phase II for High-Grade Glioma. According to GlobalData, Phase...